Overview
Some specimens, such as bone and the eyeball, cannot be processed using routine methods and require special handling before grossing and sectioning. Bone in particular must be decalcified to remove inorganic calcium before it can be sectioned on a standard microtome.
This lesson explains the composition of bone, the acid and chelating decalcifying agents available, the factors that influence decalcification rate, and the special handling required for eyeball specimens prior to sectioning.
Learning Objectives
After this lesson you will be able to…- Describe the structure and composition of bone relevant to processing
- Differentiate strong inorganic acid decalcifiers from weak organic acid decalcifiers
- Explain the principle and advantages of EDTA chelation decalcification
- List the factors influencing the rate of decalcification
- Describe the special handling steps required for eyeball specimens
Clinical Story
Why This MattersA 68-year-old woman with suspected multiple myeloma has a bone marrow trephine biopsy submitted for histopathology. Before the pathologist can examine cellular detail under the microscope, the technologist must decalcify the hard bony core completely — without damaging the antigens needed for later immunohistochemistry.
Core Concepts
Bone consists of roughly 70% mineral (mainly calcium and phosphate) and 30% organic matrix (collagen). To obtain satisfactory paraffin sections, this inorganic calcium must first be removed from the collagen matrix through decalcification, otherwise the tissue cannot be cut on a standard microtome.
Strong inorganic acids such as nitric and hydrochloric acid decalcify rapidly (useful for small biopsies within 24 hours) but cause tissue swelling and damage staining and antigenicity if used too long. Weak organic acids, principally formic acid, decalcify more gently over 1-10 days and are more suitable when immunohistochemistry is planned.
EDTA is a chelating agent that binds calcium ions without acid-related tissue damage, preserving antigenicity for immunohistochemistry and electron microscopy, though it is a very slow process taking 6-8 weeks for dense cortical bone. Eyeballs, in contrast, require immersion in formalin followed by staged equilibration in 50% ethanol over two days before sectioning to prevent shrinkage artefact.
Laboratory Principle
Decalcification removes inorganic calcium from the bone matrix either by converting it to soluble calcium salts using acids, or by chelation, in which agents like EDTA bind calcium ions directly without acid-mediated tissue damage. The choice of method balances speed against preservation of tissue morphology, staining quality, and antigenicity for downstream techniques such as immunohistochemistry.
Equipment Required
Reagents & Materials
| Reagent / Material | Concentration / Grade | Purpose | Storage |
|---|---|---|---|
| Aqueous nitric acid (5-10%) | 5-10 ml nitric acid to 100 ml distilled water | Rapid decalcification of small biopsies | Room temperature, use fresh |
| Aqueous formic acid (5-10%) | 5-10 ml 90% stock formic acid to 100 ml distilled water | Gentle decalcification preserving antigenicity | Room temperature |
| Formalin-EDTA | 5.5 g EDTA disodium salt + 90 ml water + 10 ml formaldehyde | Slow decalcification with antigen preservation | Room temperature, pH 7.0-7.4 |
Step-by-Step Procedure
Choose a strong acid (nitric/hydrochloric) for rapid decalcification of small biopsies, a weak acid (formic) for routine surgical specimens, or EDTA when antigen preservation is essential.
Place the specimen in a container with 20 times its volume of decalcifying fluid, changing the fluid periodically.
Perform a decalcification end-point test periodically (chemical or physical) to determine when all calcium has been removed.
Immerse the decalcified tissue in saturated lithium carbonate or 5-10% sodium bicarbonate solution, or rinse thoroughly in running tap water.
Once decalcification is complete and acid is neutralised, process the tissue through routine dehydration, clearing, and paraffin embedding.
Flow Diagram
Quality Control
Perform a chemical or physical decalcification end-point test on every specimen before processing to confirm complete calcium removal, avoiding both under- and over-decalcification.
Where immunohistochemistry will be performed on decalcified bone marrow specimens, periodically audit staining quality against non-decalcified control tissue to ensure the decalcification method has not compromised antigenicity.
Reference Values
Normal Ranges⚠️ Reference ranges may vary between laboratories. Always apply your laboratory's established reference intervals.
Clinical Interpretation
| Finding | Possible Significance | Action / Follow-up |
|---|---|---|
| Nuclei fail to take up haematoxylin after decalcification | Over-decalcification with strong acid, damaging tissue stainability | Reduce decalcification time or switch to a gentler agent for future specimens |
| Retained calcium deposits on sectioning (grittiness) | Incomplete decalcification | Return tissue to fresh decalcifying fluid and repeat the endpoint test |
| Loss of immunohistochemical staining | Strong acid decalcification damaged tissue antigens | Use EDTA or formic acid decalcification when IHC is planned |
Common Errors & How to Avoid Them
Cause: Prolonged exposure to strong inorganic acids beyond the recommended 24-48 hour window.
Prevention: Monitor decalcification progress with regular endpoint testing and change to a neutralising solution promptly once complete.
Cause: Insufficient time allowed, especially for large or densely mineralised bone specimens.
Prevention: Allow adequate time based on specimen size and bone type; increase decalcifying fluid volume and change it periodically.
Cause: Use of strong acid decalcifiers when immunohistochemistry is required.
Prevention: Select EDTA or buffered formic acid decalcification for specimens requiring immunohistochemical or enzyme studies.
Laboratory Tips from the Bench
Always use a 20:1 ratio of decalcifying fluid to tissue volume, and change the fluid several times during the process for even decalcification.
For needle biopsies requiring rapid diagnosis, strong acids can be used safely for up to 24 hours, but larger specimens should use gentler formic acid or EDTA.
Remember: 'Strong acid, fast but harsh; EDTA, slow but gentle' — this trade-off should guide your choice of decalcifying agent based on clinical urgency and downstream testing needs.
Important Notes
Nitric acid solutions deteriorate with use and age; old nitric acid should always be replaced with fresh stock to avoid excessive tissue damage.
Eyes should be placed in fixative as soon as possible after removal, and if already fixed in formalin, should equilibrate in 50% ethanol for two days before sectioning to restore normal volume and avoid shrinkage artefact.
Interactive Quiz
Test Your KnowledgeFlashcards
Tap to flipClick or tap any card to reveal the answer. Use arrow keys to navigate in single-card mode.
Clinical Case Study
Apply Your KnowledgePresents with back pain, anaemia, and renal impairment. Bone marrow trephine biopsy is performed for suspected multiple myeloma; immunohistochemistry for CD138 is planned.
EDTA decalcification preserved both morphological detail and antigenicity, allowing successful CD138 immunostaining to confirm a plasma cell neoplasm despite the specimen requiring decalcification.
- →EDTA decalcification is preferred when immunohistochemistry is anticipated on bone specimens.
- →Strong acid decalcification can compromise antigen preservation needed for IHC.
- →Decalcification time varies significantly with specimen size and agent chosen.
Frequently Asked Questions
The mineral content of bone (mostly calcium and phosphate) makes it too hard for a standard microtome blade; decalcification softens the tissue by removing this mineral component.
Although called an acid, EDTA does not behave like traditional acids — it works by chelating (binding) calcium ions directly rather than dissolving them through acid-base chemistry.
The eye is washed to remove formalin, then equilibrated in 50% ethanol over two days (changing the alcohol after the first day) to return the eye to a more normal volume before sectioning.
Quick Revision
10-Minute ReviewKey Takeaways
- Decalcification removes inorganic calcium so bone can be sectioned on a routine microtome.
- Acid decalcifiers are faster but more damaging; chelating agents like EDTA are gentler but slower.
- Decalcification rate depends on acid concentration, temperature, bone type, and specimen size.
- Residual acid must be neutralised after decalcification to prevent ongoing tissue damage.
- Eyeballs and bone both require special handling distinct from routine tissue processing.
- Choice of decalcifying agent should always consider downstream tests such as immunohistochemistry.
Competency Checklist
Track Your MasteryReferences
- NIOS Histology and Cytology Practical Manual, Lesson 17: Special Processing.
- Bancroft JD, Gamble M. Theory and Practice of Histological Techniques. 7th ed.
- Suvarna SK, Layton C, Bancroft JD. Bancroft's Theory and Practice of Histological Techniques. 8th ed.